Under the if-all-adhere estimand, CagriSema produced 23.0% weight loss at 84 weeks, against 25.5% for tirzepatide
To make an informed decision about compounded GLP-1 medications, you need to understand the legal framework that makes compounding possible, the specific regulatory actions that have shaped the current market, and the potential changes on the horizon
The BCL2 Family: From Apoptosis Mechanisms to New Advances in Targeted Therapy
Retinopata diabtica proliferativa: SUSTAIN-6 mostr un aumento de complicaciones de retinopata (HR 1,76), posiblemente relacionado con la correccin rpida de la hiperglucemia crnica
If a GLP-1 medication slows digestion, slows gastric emptying, or reduces appetite, edible effects may feel less predictable